- Home
- NTWK vs ITRM Comparison
NTWK vs ITRM Comparison
Compare NTWK & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTWK
- ITRM
- Stock Information
- Founded
- NTWK 1997
- ITRM 2015
- Country
- NTWK United States
- ITRM Ireland
- Employees
- NTWK N/A
- ITRM N/A
- Industry
- NTWK Computer Software: Prepackaged Software
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- NTWK Technology
- ITRM Health Care
- Exchange
- NTWK Nasdaq
- ITRM Nasdaq
- Market Cap
- NTWK 33.8M
- ITRM 40.0M
- IPO Year
- NTWK 1998
- ITRM 2018
- Fundamental
- Price
- NTWK $3.74
- ITRM $1.16
- Analyst Decision
- NTWK
- ITRM Strong Buy
- Analyst Count
- NTWK 0
- ITRM 2
- Target Price
- NTWK N/A
- ITRM $7.00
- AVG Volume (30 Days)
- NTWK 26.0K
- ITRM 583.9K
- Earning Date
- NTWK 05-14-2025
- ITRM 08-13-2025
- Dividend Yield
- NTWK N/A
- ITRM N/A
- EPS Growth
- NTWK N/A
- ITRM N/A
- EPS
- NTWK 0.02
- ITRM N/A
- Revenue
- NTWK $64,127,568.00
- ITRM N/A
- Revenue This Year
- NTWK N/A
- ITRM N/A
- Revenue Next Year
- NTWK N/A
- ITRM $270.19
- P/E Ratio
- NTWK $180.68
- ITRM N/A
- Revenue Growth
- NTWK 9.18
- ITRM N/A
- 52 Week Low
- NTWK $2.14
- ITRM $0.81
- 52 Week High
- NTWK $3.94
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- NTWK 86.95
- ITRM 61.00
- Support Level
- NTWK $3.27
- ITRM $0.91
- Resistance Level
- NTWK $3.77
- ITRM $1.03
- Average True Range (ATR)
- NTWK 0.15
- ITRM 0.05
- MACD
- NTWK 0.06
- ITRM 0.01
- Stochastic Oscillator
- NTWK 87.50
- ITRM 95.18
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.